| Tretinoin | Approved Investigational Nutraceutical | FAM30A | 9834 |
upregulated | Tretinoin results in increased expression of FAM30A mRNA | 14q32.33 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM3C | 10447 |
upregulated | Tretinoin metabolite results in increased expression of FAM3C mRNA | 7q31.31 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM3C | 10447 |
upregulated | Tretinoin results in increased expression of FAM3C mRNA | 7q31.31 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM46A | 55603 |
downregulated | Tretinoin results in decreased expression of FAM46A mRNA | 6q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM46A | 55603 |
upregulated | Tretinoin results in increased expression of FAM46A mRNA | 6q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM49B | 51571 |
downregulated | Tretinoin results in decreased expression of FAM49B mRNA | 8q24.21 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM69A | 388650 |
upregulated | Tretinoin results in increased expression of FAM69A mRNA | 1p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM78A | 286336 |
downregulated | Tretinoin results in decreased expression of FAM78A mRNA | 9q34.13 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM78B | 149297 |
upregulated | Tretinoin results in increased expression of FAM78B mRNA | 1q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM81A | 145773 |
downregulated | Tretinoin results in decreased expression of FAM81A mRNA | 15q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM83A | 84985 |
upregulated | Tretinoin results in increased expression of FAM83A mRNA | 8q24.13 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM84B | 157638 |
upregulated | Tretinoin results in increased expression of FAM84B mRNA | 8q24.21 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM86B1 | 85002 |
downregulated | Tretinoin results in decreased expression of FAM86B1 mRNA | 8p23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM86C1 | 55199 |
downregulated | Tretinoin results in decreased expression of FAM86C1 mRNA | 11q13.4 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM86EP | 348926 |
downregulated | Tretinoin results in decreased expression of FAM86EP mRNA | 4p16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FAM89B | 23625 |
upregulated | Tretinoin results in increased expression of FAM89B mRNA | 11q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FANK1 | 92565 |
upregulated | Tretinoin results in increased expression of FANK1 mRNA | 10q26.2 | |
| Tretinoin | Approved Investigational Nutraceutical | FAR2 | 55711 |
downregulated | Tretinoin results in decreased expression of FAR2 mRNA | 12p11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | FAR2 | 55711 |
upregulated | Tretinoin results in increased expression of FAR2 mRNA | 12p11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | FAS | 355 |
downregulated | Tretinoin results in decreased expression of FAS mRNA | 10q23.31 | |
| Tretinoin | Approved Investigational Nutraceutical | FAS | 355 |
upregulated | Tretinoin results in increased expression of FAS mRNA | 10q23.31 | |
| Tretinoin | Approved Investigational Nutraceutical | FASLG | 356 |
downregulated | Tretinoin results in decreased expression of FASLG mRNA | 1q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FASN | 2194 |
upregulated | Tretinoin metabolite results in increased expression of FASN mRNA | 17q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FASN | 2194 |
downregulated | Tretinoin results in decreased expression of FASN mRNA | 17q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FASTK | 10922 |
downregulated | Tretinoin metabolite results in decreased expression of FASTK mRNA | 7q36.1 | |